Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Prevalence and Prognostic Significance of Dysglicemia in Patients With Type 2 Diabetes Mellitus at the Stage of Decompensation of Chronic Cardiac Failure

Bibliographic Data

ID5968433
AuthorsM Yu Ishekova (Northern State Medical University), I V Dvoryashina (Northern State Medical University), K K Kholmatova, Kamila Kholmatova (0000-0002-5240-6470, Centre for Arctic Gas Hydrate, Environment and Climate), A M Grjibovski, Andrej М Grjibovski (0000-0002-5464-0498, North-Eastern Federal University)
Year2019
Volume26
Issue11
Pages48-54
Publication date2019-11-15
Open AccessYes
TypeARTICLE
VenueEkologiya Cheloveka (Human Ecology (JOURNAL)
Journal identifiersISSN: 1728-0869 • E-ISSN: 2949-1444
PublisherECO-Vector LLC (PUBLISHER • RU)
DOI10.33396/1728-0869-2019-11-48-54
OpenAlexW2988033460
LanguageEN
References cited14

The aim was to study the prevalence of dysglycemia and glycemic variability (GV) during hospitalization for chronic heart failure (CHF) decompensation and their effect on four-years survival. Methods: A retrospective analysis of the hospital records of 279 patients with type 2 diabetes mellitus (DM), hospitalized with CHF decompensation to the First City Clinical Hospital in Arkhangelsk was performed. Mann - Whitney tests were used for numeric variables. Simple and multiple logistic regression analyses were used to determine the effect of glycemia at admission, GV indicators on the early and long-term prognosis. Results: Median blood glucose at hospitalization was 8.80 (6.74; 11.04) mmol/l. Off-target glycemia was observed in 245 (87.8 %) patients. More than half of the measured tests during hospitalization had glycemic values beyond the recommended levels for the hospitalization period (82.6 %). In patients who died in the long-term period (n = 64, 28.1 %), hyperglycemia of more than 10.0 mmol/l was observed in 43.8 % of the measured tests during hospitalization, in 18.3 % - hyperglycemia from 7.8 to 10.0 mmol/l. Patients who died in the long-term period had higher indices of GV in comparison with the survivors (p = 0.004 for glycemic level variation, p = 0.008 for standard deviation and p = 0.001 for variation coefficient). High GV was associated (OR: 1.943; CI 1.013-3.725, p = 0.046) with the outcome, regardless of gender, manifestations of heart failure and renal function. Conclusions. Altogether, 87.8 % of patients had dysglycemia during the period of hospitalization. High GV during hospitalization was observed in 50.2 % of patients. High GV during hospitalization is an independent risk factor for for-years mortality

Cardiac decompensation · Cardiology · Decompensation · Diabetes mellitus · Glycemic · Heart failure · Insulin · Logistic regression · Cardiovascular Function and Risk Factors · Diabetes Treatment and Management · Hyperglycemia and glycemic control in critically ill and hospitalized patients · Medicine · Endocrinology · Internal Medicine

Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae